Linagliptin/Metformin fixed-dose combination treatment: a dual attack to type 2 diabetes pathophysiology.

Advances in therapy

Volumn 29, Issue 12, 2012, Pages 993-1004

  Koliaki, Chrysi ^a   Doupis, John ^b  

^a Salamis Naval Base Hospital   (Greece)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; LINAGLIPTIN; METFORMIN; PURINE DERIVATIVE; QUINAZOLINE DERIVATIVE;

ADULT; DRUG COMBINATION; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; REVIEW;

ADULT; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; PURINES; QUINAZOLINES;

EID: 85027930250     PISSN: None     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-012-0067-z     Document Type: Review

References (0)